|
FDA Likely Slow in Adopting ICH’s Final API Manufacturing Guideline
The FDA will probably take its time adopting an International Conference on Harmonisation (ICH) guideline that recommends drugmakers use risk assessments to identify material and process characteristics that could alter the critical quality attributes (CQAs) of active pharmaceutical ingredients (APIs).
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives